High glucose-induced expression of inflammatory cytokines and reactive oxygen species in cultured astrocytes

Neuroscience

Volumn 202, Issue , 2012, Pages 58-68

  Wang, J ^a   Li, G ^a   Wang, Z ^b   Zhang, X ^a   Yao, L ^b   Wang, F ^b   Liu, S ^b   Yin, J ^a   Ling, E A ^c   Wang, L ^b   Hao, A ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Astrocytes; Cytokines; High glucose; NF B; ROS; STAT 3

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VIMENTIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; BETA ACTIN GENE; CELL ACTIVATION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GENE; GENE EXPRESSION REGULATION; GENE REPRESSION; INTERLEUKIN 1 BETA GENE; INTERLEUKIN 4 GENE; INTERLEUKIN 6 GENE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA GENE; TUMOR NECROSIS FACTOR ALPHA GENE; UPREGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; FREE RADICAL SCAVENGERS; GLUCOSE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-6; MELATONIN; MICE; MICE, INBRED BALB C; NF-KAPPA B; PROLINE; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA; STAT3 TRANSCRIPTION FACTOR; THIOCARBAMATES; TRANSFORMING GROWTH FACTOR BETA; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856226348     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.062     Document Type: Article

References (58)

1. Agrawal S., Gollapudi S., Su H., Gupta S. Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol 2011, 31:472-478.
2. Akwa Y., Hassett D.E., Eloranta M.L., Sandberg K., Masliah E., Powell H., Whitton J.L., Bloom F.E., Campbell I.L. Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol 1998, 161:5016-5026.
3. Aloisi F., Penna G., Cerase J., Menéndez Iglesias B., Adorini L. IL-12 production by central nervous system microglia is inhibited by astrocytes. J Immunol 1997, 159:1604-1612.
4. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat Med 2004, 10(Suppl):S18-S25.
5. Baydas G., Reiter R.J., Yasar A., Tuzcu M., Akdemir I., Nedzvetskii V.S. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic Biol Med 2003, 35(7):797-804.
6. Bellenger J., Bellenger S., Bataille A., Massey K.A., Nicolaou A., Rialland M., Tessier C., Kang J.X., Narce M. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 2011, 60(4):1090-1099.
7. Biessels G.J., Cristino N.A., Rutten G.J., Hamers F.P., Erkelens D.W., Gispen W.H. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain 1999, 122:757-768.
8. Burge M.R., Garcia N., Qualls C.R., Schade D.S. Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis. Metabolism 2001, 50:171-177.
9. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 1993, 90:10061-10065.
10. Chavarria A., Alcocer-Varela J. Is damage in central nervous system due to inflammation?. Autoimmun Rev 2004, 3:251-260.
11. Clarke R.M., Lyons A., O'Connell F., Deighan B.F., Barry C.E., Anyakoha N.G., Nicolaou A., Lynch M.A. A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain. J Biol Chem 2008, 283:1808-1817.
12. Jacobson A.M., Musen G., Ryan C.M., Silvers N., Cleary P., Waberski B., Burwood A., Weinger K., Bayless M., Dahms W., Harth J. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007, 356:1842-1852. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group (DCCT/EDIC).
13. Di Mario U., Morano S., Valle E., Pozzessere G. Electrophysiological alterations of the central nervous system in diabetes mellitus. Diabetes Metab Rev 1995, 11:259-277.
14. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001, 33:637-668.
15. Dong Y., Benveniste E.N. Immune function of astrocytes. Glia 2001, 36:180-190.
16. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
17. Drummond K., Mauer M. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002, 51:1580-1587. International Diabetic Nephropathy Study Group.
18. Duh E., Aiello L.P. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999, 48:1899-1906.
19. Emsley J.G., Arlotta P., Macklis J.D. Star-cross'd neurons: astroglial effects on neural repair in the adult mammalian CNS. Trends Neurosci 2004, 27. 2382-2340.
20. Gaspar J.M., Castilho Á., Baptista F.I., Liberal J., Ambrósio A.F. Long-term exposure to high glucose induces changes in the content and distribution of some exocytotic proteins in cultured hippocampal neurons. Neuroscience 2010, 171:981-992.
21. Goldberg M.R., Nadiv O., Luknar-Gabor N., Zadik-Mnuhin G., Tovbin J., Katz Y. Correlation of Th1-type cytokine expression and induced proliferation to lipopolysaccharide. Am J Respir Cell Mol Biol 2008, 38:733-737.
22. Greene D.A., Stevens M.J., Obrosova I., Feldman E.L. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol 1999, 375:217-223.
23. Hoffman W.H., Andjelkovic A.V., Zhang W., Passmore G.G., Sima A.A. Insulin and IGF-1 receptors, nitrotyrosin and cerebral neuronal deficits in two young patients with diabetic ketoacidosis and fatal brain edema. Brain Res 2010, 1343:168-177.
24. Hoffman W.H., Stamatovic S.M., Andjelkovic A.V. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res 2009, 1254:138-148.
25. Jia D.Y., Du Z.H., Liu S.M., Liu H.J., Wang F.W., Ling E.A., Liu K., Hao A.J. c-Abl is involved in high glucose-induced apoptosis in embryonic E125 cortical neural progenitor cells from the mouse brain. J Neurochem 2008, 106:1720-1730.
26. Kim J.H., Min K.J., Seol W., Jou I., Joe E.H. Astrocytes in injury states rapidly produce anti-inflammatory factors and attenuate microglial inflammatory responses. J Neurochem 2010, 115:1161-1171.
27. Kishida K.T., Klann E. Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxid Redox Signal 2007, 2:233-244.
28. Korkmaz A., Reiter R.J., Topal T., Manchester L.C., Oter S., Tan D.X. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009, 15:43-50.
29. Krum J.M., Rosenstein J.M. VEGF mRNA and its receptor FLT-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp Neurol 1998, 154:57-65.
30. Kwon H.K., Hwang J.S., Lee C.G., So J.S., Sahoo A., Im C.R., Jeon W.K., Ko B.S., Lee S.H., Park Z.Y., Im S.H. Cinnamon extract suppresses experimental colitis through modulation of antigen-presenting cells. World J Gastroenterol 2011, 17:976-986.
31. Lau L.T., Yu A.C. Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury. J Neurotrauma 2001, 18:351-359.
32. Lavalette S., Raoul W., Houssier M., Camelo S., Levy O., Calippe B., Jonet L., Behar-Cohen F., Chemtob S., Guillonneau X., Combadière C., Sennlaub F. Interleukin-1β inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. Am J Pathol 2011, 178:2416-2423.
33. Little A.A., Edwards J.L., Feldman E.L. Diabetic neuropathies. Pract Neurol 2007, 7:82-92.
34. Mahesh V.B., Dhandapani K.M., Brann D.W. Role of astrocytes in reproduction and neuroprotection. Mol Cell Endocrinol 2006, 246:1-9.
35. Martindale J.L., Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002, 192:1-15.
36. Mattson M.P., Cheng B., Baldwin S.A., Smith-Swintosky V.L., Keller J., Geddes J.W., Scheff S.W., Christakos S. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: evidence for a cytoprotective response. J Neurosci Res 1995, 42:357-370.
37. McGeer E.G., McGeer P.L. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis 2010, 19:355-361.
38. Min K.J., Yang M.S., Kim S.U., Jou I., Joe E.H. Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J Neurosci 2006, 26:1880-1887.
39. Moynagh P.N. The interleukin-1 signalling pathway in astrocytes: a key contributor to inflammation in the brain. J Anat 2005, 207:265-269.
40. Northam E.A., Rankins D., Lin A., Wellard R.M., Pell G.S., Finch S.J., Werther G.A., Cameron F.J. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009, 32(3):445-450.
41. Pandey V., Chaube B., Bhat M.K. Hyperglycemia regulates MDR-1, drug accumulation and ROS levels causing increased toxicity of carboplatin and 5-fluorouracil in MCF-7 cells. J Cell Biochem 2011, 112(10):2942-2952.
42. Peairs A., Radjavi A., Davis S., Li L., Ahmed A., Giri S., Reilly C.M. Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells. Clin Exp Immunol 2009, 156:542-551.
43. Pyo H., Yang M.S., Jou I., Joe E.H. Wortmannin enhances lipopolysaccharide-induced inducible nitric oxide synthase expression in microglia in the presence of astrocytes in rats. Neurosci Lett 2003, 346:141-144.
44. Qiu C., Cotch M.F., Sigurdsson S., Garcia M., Klein R., Jonasson F., Klein B.E., Eiriksdottir G., Harris T.B., van Buchem M.A., Gudnason V., Launer L.J. Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study. Diabetes 2008, 57:1645-1650.
45. Quan Y., Jiang C.T., Xue B., Zhu S.G., Wang X. High glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathways. Acta Pharmacol Sin 2011, 32:188-1893.
46. Ridet J.L., Malhotra S.K., Privat A., Gage F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997, 20:570-577.
47. Santiago A.R., Cristóvão A.J., Santos P.F., Carvalho C.M., Ambrósio A.F. High glucose induces caspase-independent cell death in retinal neural cells. Neurobiol Dis 2007, 25:464-472.
48. Sarac K., Akinci A., Alkan A., Aslan M., Baysal T., Ozcan C. Brain metabolites changes on proton magnetic spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology 2005, 47:562-565.
49. Shanmugam N., Reddy M.A., Guha M., Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 2003, 5:1256-1264.
50. Song F., Jia W., Yao Y., Hu Y., Lei L., Lin J., Sun X., Liu L. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes. Clin Sci (Lond) 2007, 112:599-606.
51. Song H., Stevens C.F., Gage F.H. Astroglia induce neurogenesis from adult neural stem cells. Nature 2002, 417:39-44.
52. Sreekumar R., Halvatsiotis P., Schimke J.C., Nair K.S. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 2002, 51:1913-1920.
53. Tiligada E. Nuclear translocation during the cross-talk between cellular stress, cell cycle and anticancer agents. Curr Med Chem 2006, 13:1317-1320.
54. Vincent V.A., Tilders F.J., Van Dam A.M. Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta. Glia 1997, 19:190-198.
55. Wang F.W., Jia D.Y., Du Z.H., Fu J., Zhao S.D., Liu S.M., Zhang Y.M., Ling E.A., Hao A.J. Roles of activated astrocytes in bone marrow stromal cell proliferation and differentiation. Neuroscience 2009, 160:319-329.
56. Wang X., Shaw S., Amiri F., Eaton D.C., Marrero M.B. Inhibition of the Jak/STAT signaling pathway prevents the high glucose-induced increase in TGF-beta and fibronectin synthesis in mesangial cells. Diabetes 2002, 51:3505-3509.
57. Wei D., Li J., Shen M., Jia W., Chen N., Chen T., Su D., Tian H., Zheng S., Dai Y., Zhao A. Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic β-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death. Diabetes 2010, 59:471-478.
58. Zong H., Ward M., Madden A., Yong P.H., Limb G.A., Curtis T.M., Stitt A.W. Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia 2010, 53:2656-2666.